Cash management accounts (CMAs ... Our ratings take into account a product’s features, costs, consumer ratings, security and other category-specific attributes. All ratings are determined ...

Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...

As of Dec. 31, 2024, cash, cash equivalents and marketable securities totaled $231.5 million ... the current beliefs and expectations of Acumen management, and are subject to certain factors ...

The reclassification increased cash and decreased marketable securities by $5,264,000 for the year ended ... The accounting policies related to this report and additional management discussion and ...